Progenza

N/A

Report date: 2024/06/24 15:53:21

Base Information

Drug NameProgenza
Drug Alias NamePRGAdipose dreived allogeneic stem cell therapy (Cambium Bio)Allogenic adipose-derived mesenchymal stem cell therapy (Cambium Bio)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCytokines stimulantsStem cell replacements
TargetsCytokines
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCambium Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCambium Bio Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A